RESEARCH
Liquid Biopsies Can Monitor CRC Progression and Detect Residual DiseaseA translational science review in JAMA reports that circulating tumor DNA (ctDNA) sequencing can identify gene variants to inform treatment selection in colorectal cancer, and that detecting ctDNA after curative intent therapy correlates strongly with cancer recurrence and poorer outcomes. (JAMA)